Bank Of America Corp Centessa Pharmaceuticals PLC Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Bank Of America Corp holds 313,338 shares of CNTA stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

313,338

Previous 73,277 327.61%

Holding current value

$5.36 Million

Previous $661,000 657.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.58 - $16.99 $2.06 Million - $4.08 Million	240,061 Added 327.61%	313,338 $5.01 Million
Q2 2024 Aug 14, 2024	SELL	$8.04 - $11.87 $29,804 - $44,002	-3,707 Reduced 4.82%	73,277 $661,000
Q1 2024 May 15, 2024	BUY	$6.73 - $12.2 $268,890 - $487,438	39,954 Added 107.9%	76,984 $869,000
Q4 2023 Feb 14, 2024	BUY	$5.52 - $8.03 $181,160 - $263,536	32,819 Added 779.36%	37,030 $294,000
Q2 2023 Aug 14, 2023	BUY	$3.68 - $6.9 $10,767 - $20,189	2,926 Added 227.7%	4,211 $26,000
Q1 2023 May 12, 2023	SELL	$3.03 - $4.0 $2,142 - $2,828	-707 Reduced 35.49%	1,285 $4,000
Q4 2022 Feb 10, 2023	BUY	$3.05 - $4.19 $5,569 - $7,650	1,826 Added 1100.0%	1,992 $6,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $22,344 - $34,750	-5,880 Reduced 97.25%	166 $0
Q2 2022 Aug 12, 2022	SELL	$3.18 - $9.85 $121,256 - $375,590	-38,131 Reduced 86.31%	6,046 $29,000
Q1 2022 May 16, 2022	SELL	$7.45 - $11.59 $261,256 - $406,438	-35,068 Reduced 44.25%	44,177 $396,000
Q4 2021 Feb 08, 2022	BUY	$10.99 - $17.54 $840,141 - $1.34 Million	76,446 Added 2731.19%	79,245 $892,000
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $6,696 - $9,267	401 Added 16.72%	2,799 $46,000
Q2 2021 Sep 13, 2021	BUY	$21.71 - $25.66 $52,060 - $61,532	2,398 New	2,398 $54,000

Others Institutions Holding CNTA

# of Institutions

108

Shares Held

118M

Call Options Held

5.9K

Put Options Held

53K

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.61B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Centessa Pharmaceuticals PLC Transaction History